Eugene R. Cooper
55Patents
22h-index
56Co-inventors
91Inventor score
Filing activity: Jun 25, 1979 → Jul 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4557934A | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one | Human Necessities | 197 | Expired |
| US4954487A | Penetrating topical pharmaceutical compositions | Human Necessities | 175 | Expired |
| US4537776A | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone | Human Necessities | 165 | Expired |
| US6428814B1 | Bioadhesive nanoparticulate compositions having cationic surface stabilizers | Human Necessities | 153 | Expired |
| US4552872A | Penetrating topical pharmaceutical compositions containing corticosteroids | Human Necessities | 142 | Expired |
| US6811767B1 | Liquid droplet aerosols of nanoparticulate drugs | Human Necessities | 142 | Expired |
| US5565188A | Polyalkylene block copolymers as surface modifiers for nanoparticles | Emerging Cross-Sectional Technologies | 120 | Expired |
| US5221696A | Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs | Human Necessities | 109 | Expired |
| US5585108A | Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays | Human Necessities | 106 | Expired |
| US8512727B2 | Nanoparticulate meloxicam formulations | Emerging Cross-Sectional Technologies | 106 | Expired |
| US5318767A | X-ray contrast compositions useful in medical imaging | Performing Operations; Transporting | 104 | Expired |
| US6908626B2 | Compositions having a combination of immediate release and controlled release characteristics | Human Necessities | 86 | Expired |
| US7585517B2 | Transscleral delivery | Human Necessities | 78 | Active |
| US4392848A | Catheterization | Human Necessities | 69 | Expired |
| US5618528A | Biologically compatible linear block copolymers of polyalkylene oxide and peptide units | Human Necessities | 59 | Expired |
| US5451393A | X-ray contrast compositions useful in medical imaging | Performing Operations; Transporting | 58 | Expired |
| US5466440A | Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays | Performing Operations; Transporting | 56 | Expired |
| US5705194A | Pharmaceutical compositions containing polyalkylene block copolymers which gel at physiological temperature | Emerging Cross-Sectional Technologies | 42 | Expired |
| US7198795B2 | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions | Human Necessities | 39 | Expired |
| US7763278B2 | Nanoparticulate polycosanol formulations and novel polycosanol combinations | Human Necessities | 36 | Expired |
| US7288267B2 | Bioadhesive nanoparticulate compositions having cationic surface stabilizers | Human Necessities | 32 | Expired |
| US8623412B2 | Abuse-resistant pharmaceutical compositions | Human Necessities | 24 | Active |
| US5368837A | X-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivative | Human Necessities | 19 | Expired |
| US7521068B2 | Dry powder aerosols of nanoparticulate drugs | Human Necessities | 17 | Expired |
| US5318768A | Polymeric x-ray contrast compositions containing an organic crystalline x-ray contrast agent | Performing Operations; Transporting | 13 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.